QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 19, Issue 12, 5309-5326, December 2008

This Article Abstract Full Text (PDF) Supplemental Materials All Versions of this Article: E08-07-0712v1 19/12/5309    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Keyel, P. A. Articles by Traub, L. M. Search for Related Content PubMed PubMed Citation Articles by Keyel, P. A. Articles by Traub, L. M.

The AP-2 Adaptor β2 Appendage Scaffolds Alternate Cargo Endocytosis

Peter A. Keyel^*,,, James R. Thieman^*,, Robyn Roth, Elif Erkan^||, Eric T. Everett^¶, Simon C. Watkins^*, John E. Heuser, and Linton M. Traub^*

*Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110; ^||Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; and ^¶Department of Pediatric Dentistry and The Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599

Submitted July 11, 2008; Revised September 19, 2008; Accepted September 30, 2008
Monitoring Editor: Sandra Lemmon

	ABSTRACT

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
The independently folded appendages of the large and β2 subunits of the endocytic adaptor protein (AP)-2 complex coordinate proper assembly and operation of endocytic components during clathrin-mediated endocytosis. The β2 subunit appendage contains a common binding site for β-arrestin or the autosomal recessive hypercholesterolemia (ARH) protein. To determine the importance of this interaction surface in living cells, we used small interfering RNA-based gene silencing. The effect of extinguishing β2 subunit expression on the internalization of transferrin is considerably weaker than an AP-2 subunit knockdown. We show the mild sorting defect is due to fortuitous substitution of the β2 chain with the closely related endogenous β1 subunit of the AP-1 adaptor complex. Simultaneous silencing of both β1 and β2 subunit transcripts recapitulates the strong subunit RNA interference (RNAi) phenotype and results in loss of ARH from endocytic clathrin coats. An RNAi-insensitive β2-yellow fluorescent protein (YFP) expressed in the β1 + β2-silenced background restores cellular AP-2 levels, robust transferrin internalization, and ARH colocalization with cell surface clathrin. The importance of the β appendage platform subdomain over clathrin for precise deposition of ARH at clathrin assembly zones is revealed by a β2-YFP with a disrupted ARH binding interface, which does not restore ARH colocalization with clathrin. We also show a β-arrestin 1 mutant, which engages coated structures in the absence of any G protein-coupled receptor stimulation, colocalizes with β2-YFP and clathrin even in the absence of an operational clathrin binding sequence. These findings argue against ARH and β-arrestin binding to a site upon the β2 appendage platform that is later obstructed by polymerized clathrin. We conclude that ARH and β-arrestin depend on a privileged β2 appendage site for proper cargo recruitment to clathrin bud sites.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Clathrin-mediated endocytosis is a process through which many nutrient and signaling receptors, ion channels, and even pathogens, are internalized from the cell surface and delivered to endosomes. The process requires the fine coordination of cargo selection, membrane invagination, and actin dynamics (Conner and Schmid, 2003; Robinson, 2004; Edeling et al., 2006b; Kaksonen et al., 2006). At the plasma membrane, these diverse processes are managed, in part, by the adaptor protein (AP)-2 heterotetramer. The brick-like AP-2 core is composed of a small 2 subunit, the cargo-selective µ2 subunit, along with the N-terminal trunks of two large chains, the and β2 subunits (Collins et al., 2002; see Figure 4A). Projecting off both and β2 subunit trunks, via flexible hinges, are bilobal appendages that contain binding sites for clathrin and numerous other endocytic proteins (Robinson, 2004; Edeling et al., 2006b; Schmid and McMahon, 2007).

The four assembled subunits permit AP-2 to coordinate various aspects of clathrin coat formation. The plasma membrane-enriched lipid phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P₂] is engaged by both the and µ2 subunits (Gaidarov and Keen, 1999; Höning et al., 2005). YXXØ-type sorting signals (as found in the transferrin receptor) are bound directly by the µ2 subunit (Ohno et al., 1995), whereas [DE]XXXL[LIM] dileucine signals are recognized by a functional hemicomplex of the and 2 subunit (Janvier et al., 2003; Coleman et al., 2005; Chaudhuri et al., 2007). Various assembly protein and clathrin associations are established through the and β2 appendages (Wang et al., 1995; McPherson and Ritter, 2005; Traub, 2005; Edeling et al., 2006b; Schmid and McMahon, 2007). The appendage has two interaction surfaces, one each upon the platform and sandwich subdomains. The platform site can bind to DP[WF] and FXDXF interaction motifs (Brett et al., 2002; Praefcke et al., 2004), whereas the sandwich site engages the WXX[FW]X_n[DE] motif (Mishra et al., 2004; Praefcke et al., 2004; Ritter et al., 2004; Walther et al., 2004). These short interaction sequences are typically positioned within tracts of intrinsically unstructured polypeptide, and proteins bearing the former class of motifs are typically involved in cargo selection and lattice polymerization. Proteins bearing the latter set generally include regulatory proteins such as adaptor-associated kinase 1, cyclin G-dependent kinase, and the phosphoinositide polyphosphatase synaptojanin 1 (Jha et al., 2004; Praefcke et al., 2004; Walther et al., 2004). Some of the regulatory proteins, such as synaptojanin 1, also contain platform binding sites, potentially allowing them to compete previously bound clathrin-associated sorting proteins (CLASPs) off AP-2 (Mishra et al., 2004; Praefcke et al., 2004). Thus, the appendage regulates the temporal organization of the developing clathrin lattice through binding sites that permit the recruitment of first lattice assembly and cargo selective factors, followed by regulatory proteins that control bud formation and likely promote release of proteins from AP-2 once their role in endocytosis is complete.

Similar to the appendage, the structurally related β2 appendage also contains two interaction surfaces, one surface analogous to the appendage-platform site, and one surface positioned on the opposite side from the cognate appendage-sandwich site (Edeling et al., 2006a; Schmid et al., 2006). The contact sites on the β2 appendage do not seem to control accessory proteins in precisely the same manner as the hierarchical appendage binding sites. Biochemical studies suggest the β2 appendage-platform site is largely dedicated to CLASPs, such as the β-arrestins, which concentrate G protein-coupled receptors (GPCRs) (Kim and Benovic, 2002; Laporte et al., 2002; Milano et al., 2002); the autosomal recessive hypercholesterolemia (ARH) protein, which decodes the FXNPXY-type sorting signal (He et al., 2002; Mishra et al., 2002b); and epsin 1, which recognizes poly/multiubiquitinated cargo (Barriere et al., 2006; Hawryluk et al., 2006). These discrete classes of cargo internalization signal do not bind directly to AP-2. The β2 appendage-sandwich site, along with a type I clathrin box in the β2-hinge, allows AP-2 to polymerize clathrin and regulate eps15 positioning within the assembling lattice (Cupers et al., 1998; Owen et al., 2000; Edeling et al., 2006a). Thus, the β2 subunit contains functionally distinct binding sites that could simultaneously allow privileged access of certain CLASPs to the lattice along with clathrin recruitment. Overall, AP-2 acts as a master adaptor, binding to the plasma membrane, sorting YXXØ- and [DE]XXXL[LIM]-bearing cargo, and coordinating clathrin vesicle formation while simultaneously providing access for alternative types of cargo by scaffolding CLASPs. Accordingly, targeted gene disruption or mutation of AP-2 µ2 or subunit genes is homozygous lethal in mice (Mitsunari et al., 2005), Drosophila (Gonzalez-Gaitan and Jackle, 1997), and Caenorhabditis elegans (Shim and Lee, 2000).

In humans, inherited deficiency of one CLASP, ARH, results in a pathological hypercholesterolemia similar to, but less severe than, familial hypercholesterolemia (Eden et al., 2001; Garcia et al., 2001). Structurally, ARH contains a phosphotyrosine binding (PTB) domain that binds simultaneously to both FXNPXY peptides and PtdIns(4,5)P₂ and an unstructured C terminus containing a type I clathrin box and the β2 appendage-binding sequence (Eden et al., 2002; He et al., 2002; Mishra et al., 2002b). Functionally, it may play an analogous role to the β-arrestins, which use a related, helical [DE]_nX_1-2FXX[FL]XXXR β2-binding sequence to usher GPCRs to preformed clathrin coats (Laporte et al., 2000; Kim and Benovic, 2002; Milano et al., 2002; Edeling et al., 2006a; Hamdan et al., 2007). ARH may likewise use primarily the β2 appendage-binding site, rather than the clathrin box, to shuttle or retain low density lipoprotein (LDL) receptors in clathrin structures.

To test ARH dependence on β2 appendage binding, we replaced endogenous AP-2 β2 subunits with various β2-yellow fluorescent protein (YFP) mutants by using RNA interference (RNAi). When characterizing the β2 subunit knockdown necessary for this approach, we found that simultaneous depletion of the β1 subunit from the related trans-Golgi network (TGN)/endosome-localized AP-1 complex is also necessary, because, otherwise, the highly related, endogenous β1 subunit compensates for β2 subunit depletion. In the context of a β1 + β2 subunit knockdown, the β2 subunit trunk is sufficient to rescue known AP-2 knockdown phenotypes (Hinrichsen et al., 2003; Motley et al., 2003), clustering transferrin in clathrin coats and restoring cellular AP-2 levels, although ARH surface localization is clearly disrupted. Rescue of the β1 + β2 subunit knockdown with a full-length β2-YFP bearing a point mutation in the β2-platform subdomain also fails to recover ARH localization to clathrin structures, whereas both wild-type β2-YFP or β2-YFP lacking clathrin binding sites restore ARH localization to clathrin puncta. This suggests that AP-2 is vital both as the YXXØ-selective CLASP and as a scaffold controlling endocytic protein recruitment to clathrin-coated pits during endocytosis.

	MATERIALS AND METHODS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Plasmids, Small Interfering RNA (siRNA) and Antibodies
The siRNA duplexes used target base pairs 1384-1402 of the human β2 subunit (Huang et al., 2004) (Dharmacon RNA Technologies, Lafayette, CO), base pairs 1529-1537 of the human β1 subunit (Invitrogen, Carlsbad, CA or Dharmacon RNA Technologies), and base pairs 1052-1069 of the subunit transcript (Dharmacon RNA Technologies) (Keyel et al., 2006). All siRNA oligonucleotides were synthesized with dTdT overhangs. The β2-YFP plasmid was a kind gift from Alexander Sorkin (University of Colorado at Denver, Aurora, CO; Sorkina et al., 2002). Generation of the β2-YFP mutants and truncation has been described previously (Keyel et al., 2006). The tandem dimer tomato (tdRFP)-β-arrestin 1 was generated by first replacing enhanced green fluorescent protein (EGFP) with tdRFP (Shaner et al., 2004) between the NheI and BspE1 restriction sites in pEGFP-C1, followed by insertion of full-length Bos taurus β-arrestin 1 between XhoI and SalI sites. The β2-YFP platform (Y888V) and sandwich (Y815A) subdomain mutants, the clathrin-box deleted (LLDLD) mutant, the tdRFP-β-arrestin 1 paired I386A and V387A (IVAA) constitutively active mutant, and the clathrin box ³⁷⁶LIELAAEA mutation or clathrin-box-deleted LIELD were all generated using QuikChange mutagenesis (Stratagene, La Jolla, CA).

The anti-clathrin heavy chain (HC) monoclonal antibody (mAb) TD.1 (Nathke et al., 1992) and X22 (Brodsky, 1985), the AP-1/2 β1/β2 subunit mAb 100/1 (Ahle et al., 1988) and affinity-purified antibody GD/1 (Traub et al., 1999), the AP-2 subunit mAb AP.6 (Chin et al., 1989), the anti-AP-1 subunit antibody AE/1 (Traub et al., 1995), the anti-AP-1 µ1 subunit antibody RY/1 (Traub et al., 1995), the anti-ARH antibody (Mishra et al., 2002b), the anti-cation–independent mannose 6-phosphate receptor (MPR) antibody (Zhu et al., 1999), the anti-epsin 1 polyclonal antibody (Drake et al., 2000), and the anti-disabled-2 (Dab2) polyclonal antibody (Mishra et al., 2002a) have been described previously. Affinity-purified anti-eps15 polyclonal was kindly provided by Ernst Ungewickell (Medizinische Hochschule Hannover, Hannover, Germany; Hinrichsen et al., 2003). The anti-transferrin receptor mAb H68.4 was a gift from Ian Trowbridge (The Salk Institute, La Jolla, CA; White et al., 1992), rabbit R11-29 anti-AP-2 µ2 subunit serum was kindly provided by Juan Bonifacino (National Institutes of Health, Bethesda, MD; Aguilar et al., 1997), the anti-lysosome–associated membrane protein (LAMP)-1 mAb G1/139 was kindly provided by Jack Rohrer (Zürcher Hochschule für Angewandte Wissenschaften, Wadenswil, Switzerland; Rohrer et al., 1996), and anti-green fluorescent protein (GFP) polyclonal antibody B5 was generously provided by Phyllis Hanson (Washington University School of Medicine, St. Louis, MO; Dalal et al., 2004). Anti-AP-2 subunit mAb clone 8 and the anti-AP-1 subunit mAb clone 88 were both from BD Biosciences Transduction Laboratories (Lexington, KY). The anti-β-arrestin polyclonal antibody was purchased from Sigma-Aldrich (St. Louis, MO), the anti-tubulin mAb E7 was from the Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, IA), and a hybridoma secreting anti-LDL receptor mAb IgG-C7 was from the American Type Culture Collection (Manassas, VA). Horseradish peroxidase-conjugated donkey anti-mouse and anti-rabbit, Cy5-conjugated goat anti-mouse, and 15-nm gold-conjugated anti-mouse secondary antibodies were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA), whereas Alexa Fluor 488 angiotensin II, Alexa Fluor 488-, and Alexa Fluor 568-conjugated goat anti-mouse and anti-rabbit secondary antibodies were obtained from Invitrogen.

Cell Culture, RNAi, and Reconstitution
HeLa SS6 cells (Elbashir et al., 2001) were cultured at 37°C humidified with 5% CO₂ in DMEM supplemented with 10% fetal calf serum and 2 mM L-glutamine (Invitrogen). A line of HeLa SS6 cells stably expressing β2-YFP was selected in the same medium supplemented with 0.5 mg/ml G-418 (Invitrogen). Analysis of these cells shows that <10% of cellular AP-2 contains the YFP-tagged β2 subunit. Wild-type (+/+) and AP-2 β2 subunit homozygous mutant (β2 –/–) mouse embryonic fibroblasts were cultured in DMEM supplemented with 10% fetal calf serum, 2 mM L-glutamine, and 1x antibiotic/antimycotic mixture (Sigma-Aldrich). β-Arrestin nullizygous mouse embryonic fibroblasts were kindly provided by Robert Lefkowitz (Kohout et al., 2001). Cells were maintained in DMEM supplemented with 10% fetal calf serum and 2 mM L-glutamine. Human embryonic kidney (HEK) 293 cells stably expressing a FLAG-tagged type I angiotensin II receptor were kindly provided by Stéphane Laporte (McGill University, Montreal, Quebec, Canada), and they were cultured in Earle's minimal essential medium. RNAi and reconstitution were performed as described previously (Keyel et al., 2006). For rescue experiments, 100 ng of rescue DNA was included along with the siRNA duplexes at the time of transfection and did not block RNAi-mediated knockdown of the targeted proteins (Supplemental Figure S2).

Immunofluorescence
HeLa SS6 cells were prepared for immunofluorescence as described previously (Mishra et al., 2005). To visualize only the plasma membrane associated clathrin, or only AP-2 with the anti-β1/β2 antibody GD/1, cells were treated with 10 µg/ml brefeldin A (Epicenter Technologies, Madison, WI) for 15 min, followed by permeabilization in 0.3% saponin, 25 mM HEPES-KOH, pH 7.2, 125 mM potassium acetate, and 5 mM magnesium acetate for 1 min on ice before fixation to remove cytosolic and ARF-dependent clathrin and AP-1. For experiments involving LDL receptors, the cells were grown in DMEM supplemented with 10% lipoprotein-deficient serum (Cocalico Laboratories, Reamstown, PA), 2 mM L-glutamine for 24–48 h to up-regulate LDL receptors, whereas for experiments involving transferrin, cells were placed in DMEM supplemented with 25 mM HEPES-KOH, pH 7.2, and 0.5% bovine serum albumin (starvation medium) for 1 h before experiments to unload the receptors. To measure surface levels of receptors, cells were incubated with either the appropriate antibody or 25 µg/ml transferrin conjugated to Alexa Fluor 568 (Tf568) (Invitrogen) in starvation medium for 1 h on ice at 4°C and fixed for immunofluorescence. To measure the amount of internalized receptors, cells were either incubated on ice as described above and then washed and warmed to 37°C for 15 min before fixation (see Figures 1 and 7); or after the 1 h in starvation medium, maintained in the continuous presence of 25 µg/ml Tf568 or 50 µg/ml Tf633 (Invitrogen) for 15 min at 37°C before fixation (see Figures 6 and 7). Alexa 488-labeled angiotensin II (100 nM) was added at 37°C for 5 or 20 min. For imaging of surface transferrin receptor-labeled fibroblasts, 25 µg/ml Tf488 was bound at 4°C for 1 h in starvation media. Cells were washed once and imaged at 4°C in starvation media using a temperature-controlled stage mount (Harvard Apparatus, Holliston, MA).

Immunoprecipitation
HeLa SS6 cells grown in six-well plates, treated or untreated with siRNA against β2 subunit as described above, were trypsinized, washed in phosphate-buffered saline (PBS), and lysed in 10 mM HEPES-KOH, pH 7.2, 0.3 M sucrose, 1% Triton X-100, and Complete mini-protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany) for 30 min on ice. Cell debris was removed by centrifugation at 18,000 x g_max for 10 min at 4°C, and the supernatants frozen on dry ice and stored at –80°C until use. The samples were thawed and incubated with 2 µg of anti- subunit mAb AP.6 for 1 h at 4°C with gentle shaking, followed by the addition of protein G-coupled beads (Sigma-Aldrich), an additional hour at 4°C with gentle shaking, and then centrifugation to separate supernatant from pellet. The pellets were washed extensively in PBS and 1% Triton X-100, and then they were mixed with SDS sample buffer such that one-eighth of the pellet and 1/25 of the supernatant were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE). AP-2 was similarly immunoprecipitated from lysates of embryonic fibroblasts prepared in 10 mM HEPES-KOH, pH 7.2, 0.3 M sucrose, 500 mM Tris-HCl, 1% Triton X-100, Complete mini-protease inhibitor cocktail, and 1 mM phenylmethylsulfonyl fluoride. After centrifugation to remove insoluble material, lysates were diluted fourfold before addition of 5 µg of mAb AP.6. Electrophoresis and immunoblotting was as described previously (Keyel et al., 2006). Blots were quantitated by measuring the integrated intensity of a fixed region containing the band in MetaMorph (MDS Analytical Technologies, Sunnyvale, CA), subtracting that intensity from the background in a similarly sized region, and normalizing expression to clathrin expression. Normalized expression levels were compared with those of mock-transfected cells to determine up- or down-regulation of AP-1 and AP-2 subunits under the various RNAi conditions.

Microscopy
Images were acquired on a FluoView FV500 or FV1000 confocal microscope (Olympus, Tokyo, Japan) as described previously (Keyel et al., 2006). Quantitation of ARH clathrin coat localization was performed using MetaMorph software (MDS Analytical Technologies) by measuring the integrated intensity of ARH staining in cell surface confocal sections that were either control (normal transferrin internalization), knocked down (blocked transferrin internalization), or rescued (YFP expression) and subtracting the intensity of knockdown cells from that of either mock transfected or neighboring rescued cells. The number of clathrin and AP-2 ( subunit) puncta were determined by manually counting all puncta within a 10 x 10 µm (clathrin) or 6 x 6 µm (AP-2) portion of cells from multiple fields and independent experiments expressing very low levels of clathrin/AP-2 (AP-2 knocked down cells) or cells expressing wild-type levels of the protein (mock). Statistical significance was determined using Student's t test. Cells with surface transferrin, transferrin uptake or AP-2 ( subunit) intensity phenotypes were manually counted in MetaMorph (MDS Analytical Technologies) as either normal or impaired, and the total percentage of cells either expressing or not expressing β2-YFP determined. Impaired phenotypes consisted of loss of transferrin localization to coated pits, very low levels of internalized transferrin, or AP-2 subunit intensities on a par with those found with AP-2 subunit siRNA. These percentages were averaged for two to three independent experiments and significance determined using a one-tailed Student's t test.

Total internal reflection fluorescence microscopy (TIR-FM) was performed as described previously (Keyel et al., 2004), with some modifications. Images were collected with a thermoelectrically cooled Cascade II 512 camera (Photometrics, Tucson, AZ). Data sets were collected with MetaMorph software at 1 frame/5 s. For quantification of colocalization of tdRFP-β-arrestin 1 with AP-2 in β2-YFP–expressing cells, an average of 55 spots/cell in 11-15 individual cells were analyzed.

Adherent plasma membrane from cells treated with subunit siRNA as described above were prepared for rapid-freeze, deep-etch electron microscopy as described previously (Heuser, 2000). Briefly, cells grown on small oriented pieces of glass coverslip were disrupted by sonication, fixed in paraformaldehyde, and labeled with anti-transferrin receptor mAb H68.4 and then 15-nm gold-conjugated anti-mouse antibody before flash freezing in liquid helium (Keyel et al., 2006).

	RESULTS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Gene Silencing of the AP-2 Subunit
In HeLa SS6 cells, we find transfection of siRNA duplexes targeting the AP-2 subunit mRNA reduces the protein level of all four adaptor subunits >75% within 48 h (Figure 1A and Supplemental Figure 1A), in very good agreement with previous results (Hinrichsen et al., 2003; Motley et al., 2003). Depletion of AP-2 is also seen morphologically, as a sharp decrease in the intensity of surface AP-2–positive puncta compared with the control cells (Figure 1B). It is known that AP-2 knockdown reduces the amount of clathrin positioned at the plasma membrane but not that recruited to other structures or total cytoplasmic amounts (Hinrichsen et al., 2003; Motley et al., 2003). To selectively visualize clathrin at the plasma membrane, we briefly treated cells with brefeldin A to dissociate clathrin from internal membrane structures, and then we rapidly permeabilized the cells before fixation (Figure 1, C and D). In mock-transfected cells, this treatment effectively eliminates TGN, endosomal and cytosolic clathrin, without perturbing the plasma membrane associated clathrin pool. No AP-1 subunit staining is observed, and the remaining β subunit signal is fully sensitive to subunit RNAi (Figure 1C). Although the total amount of clathrin recruited to the plasma membrane is greatly diminished upon AP-2 subunit RNAi (Figure 1D), we do not observe that the total number of surface puncta decreases >10-fold as reported originally (Hinrichsen et al., 2003; Motley et al., 2003). Rather, in subunit–silenced cells, although very dim, the number of discrete clathrin- and AP-2–containing surface structures is 73.2 and 70.7% that of control, respectively. The discrepancy is probably because AP-2 complexes are not completely eliminated under our single transfection RNAi conditions (Figure 1B).

View larger version (86K): [in this window] [in a new window]   Figure 1. siRNA-mediated gene silencing of the AP-2 subunit. (A) Lysates of HeLa SS6 cells untreated (lanes a and b) or treated with AP-2 subunit siRNA (lanes c and d) were resolved by SDS-PAGE and either Coomassie stained or transferred to nitrocellulose. Sections of the blots were probed with anti-AP-2 subunit mAb clone 8, anti-clathrin heavy chain (HC) mAb TD.1, anti-β1/β2 subunit mAb 100/1, anti-AP-2 µ2 antiserum, or anti-tubulin mAb E7, and only the relevant portion of each blot shown. The position of molecular mass standards (in kilodaltons) is indicated on the left. (B–D) HeLa SS6 cells untreated (left) or treated with AP-2 subunit siRNA (right) were treated with 10 µg/ml brefeldin A for 15 min, permeabilized on ice for 1 min before fixation, and prepared for immunofluorescence using the anti-AP-2 subunit mAb AP.6 (B), anti-AP-1 subunit mAb (C; green), anti-β1/β2 subunit antibody GD/2 (C; red), or anti-clathrin heavy chain mAb X22 (D). (E–G) HeLa SS6 cells untreated (left) or treated with AP-2 subunit siRNA (right) were incubated on ice for 1 h with either anti-LDL receptor mAb C7 (E; green), Tf568 (E, red and F), anti-LAMP-1 mAb (G; green), or anti-MPR antibody (G; red) and fixed (E and G) or washed and warmed to 37°C for 15 min and fixed (F) followed by indirect immunofluorescence. Bar, 10 µm.

To better understand at the ultrastructural level how the AP-2 knockdown affects clathrin lattice assembly at the cell surface, adherent plasma membranes of mock- and subunit siRNA-treated cells were analyzed by immunogold freeze-etch electron microscopy. AP-2 knocked down cells can be unambiguously identified with mAb H68.4. This antibody detects an epitope located near the amino terminus of the human transferrin receptor that overlaps with the YTRF internalization signal (White et al., 1992). Transferrin receptors positioned within clathrin lattices by engagement of the AP-2 µ2 subunit are not recognized by this mAb; only the extra-lattice population of the receptor is detected (White et al., 1992). In our images, compared with mock-transfected cells (Figure 2A), the frequency of gold labeling in the AP-2 gene-silenced cells is increased, especially the population >100 nm from assembled clathrin lattices (Figure 2, B–D). In the siRNA-transfected cells, the discernible clathrin coats are substantially smaller than normal (Motley et al., 2003), concordant with the immunofluorescence data (Figure 1) and the capability of CLASPs like Dab2 and epsin to promote clathrin lattice assembly (Drake et al., 2000; Morris and Cooper, 2001; Kalthoff et al., 2002; Mishra et al., 2002a). Despite the limited dimensions, both flattened lattices and invaginating buds are visible. Overall, we conclude that the knockdown of the subunit of AP-2 ablates AP-2 sorting activity with similar functional consequences as reported initially (Hinrichsen et al., 2003; Motley et al., 2003), except that our knockdown procedure does not decrease as dramatically the total number of surface clathrin-containing structures.

View larger version (179K): [in this window] [in a new window]   Figure 2. AP-2 knocked down cell ultrastructure. HeLa SS6 cells either mock transfected (A) or transfected with subunit siRNA oligonucleotides (B–D) were briefly sonicated to prepare cell cortices, fixed, labeled with anti-transferrin receptor mAb H68.4, and then 15-nm gold-conjugated anti-mouse secondary antibodies to visualize extra-lattice receptors. Arrows indicate gold-labeled receptors.

View larger version (66K): [in this window] [in a new window]   Figure 3. AP-2 β2 subunit gene silencing. (A) Lysates of HeLa SS6 cells untreated (lane a) or treated with either AP-2 or β2 subunit siRNA (lanes b and c) were resolved by SDS-PAGE and either Coomassie stained or transferred to nitrocellulose. Sections of the blots were probed with anti-clathrin HC mAb TD.1, anti-AP-2 subunit mAb clone 8, anti-β1/β2 subunit mAb 100/1, anti-AP-2 µ2 antiserum, or anti-AP-1 subunit antibody AE/1, and only the relevant portion of the blots is shown. The position of molecular mass standards (in kilodaltons) is indicated on the left. (B and C) HeLa SS6 cells untreated (left) or treated with AP-2 - (middle), or β2 subunit siRNA (right) were treated with 10 µg/ml brefeldin A for 15 min, permeabilized on ice for 1 min before fixation, and prepared for immunofluorescence using the anti-AP-2 subunit mAb AP.6 (B, green), anti-β1-/β2 subunit antibody GD/2 (B; red), or anti-clathrin HC mAb X22 (C). (D and E) HeLa SS6 cells untreated (left) or treated with AP-2 (middle) or β2 subunit (right) siRNA were incubated on ice for 1 h with either anti-LAMP-1 mAb (D; green) and anti-MPR antibody (D; red), or anti-LDL receptor mAb C7 (E; green) and Tf568 (E; red), fixed, and prepared for indirect immunofluorescence. The inset in E shows Tf568 immunofluorescence from each sample.

View larger version (13K): [in this window] [in a new window]   Figure 4. β1 subunit rescues β2 subunit knockdown of AP-2. (A) Schematic diagram of AP-1 and AP-2 complex composition and subunit homology. (B) Lysates from either untreated or β2 siRNA-treated HeLa SS6 cells were prepared and AP-2 immunoprecipitated using the anti- subunit mAb AP.6. Aliquots of the supernatant and precipitate fractions from both control and β2 RNAi samples were resolved by SDS-PAGE and transferred to nitrocellulose. Blots were probed with the anti-AP-2 subunit mAb clone 8, anti-β1/β2 subunit antibody mAb 100/1, anti-clathrin HC antibody mAb TD.1, or anti-AP-2 µ2 antiserum, and only the relevant portion of each blot is shown.

View larger version (51K): [in this window] [in a new window]   Figure 5. Stable incorporation of the β1 subunit into AP-2 in β2 subunit-null mouse fibroblasts. (A) Aliquots of lysates from either control +/+ (lane a) or β2-null –/– (lane c) mouse embryonic fibroblasts and of mAb AP.6 immunoprecipitates from the +/+ (lane b) or –/– (lane d) lysates were resolved by SDS-PAGE and transferred to nitrocellulose. Blots were probed with anti-clathrin HC mAb TD.1 and affinity purified anti-β1/β2 subunit polyclonal GD/1, anti-AP-2 subunit mAb clone 8, anti-AP-2 µ2 subunit antiserum, or affinity-purified anti-µ1 subunit polyclonal RY/1, and only the relevant portion of each blot is shown. The asterisk indicates a nonspecific band. Loss of β2-chain expression results in a compensatory increase in the steady-state level of the β1 subunit in the cultured fibroblasts, although the level of AP-2 is nevertheless reduced compared with wild-type fibroblasts. (B–E) Wild-type (+/+; left column) or β2-null (–/–; right column) mouse embryonic fibroblasts were fixed and labeled with Hoechst 33258, anti- subunit mAb AP.6 and either anti-β1/β2 subunit GD/1 (B), anti-Dab2 (C), anti-epsin (D), or anti-eps15 (E) polyclonal antibodies. Representative confocal sections of the ventral plasma membrane are shown. In all cases, absence of β2 does not obviously perturb the punctate patterning of the subunit or CLASPs. Bar, 10 µm.

View larger version (78K): [in this window] [in a new window]   Figure 6. β1 + β2 subunit RNAi recapitulates subunit RNAi phenotype. (A) Lysates of HeLa SS6 cells untreated (lane a) or treated with either AP-1 β1 (lane b), AP-2 β2 (lane c), or β1 + β2 subunit siRNAs (lane d) were resolved by SDS-PAGE and either Coomassie stained or transferred to nitrocellulose. Sections of the blots were probed with the anti-clathrin HC mAb TD.1 and anti-β1/β2 subunit mAb 100/1, anti-AP-2 subunit mAb clone 8, anti-AP-2 µ2 subunit antiserum, anti-AP-1 subunit antibody AE/1, or anti-AP-1 µ1 subunit antibody RY/1 polyclonal antibodies, and only the relevant portions are shown. The position of molecular mass standards (in kilodaltons) is indicated on the left. (B–D) HeLa SS6 cells were either untreated (left), treated with either AP-2 subunit siRNA (middle), or both AP-1 β1 and AP-2 β2 subunit siRNA (right). Next, they were either fixed and probed with anti-AP-2 subunit mAb AP.6 (B), brefeldin treated and permeabilized on ice before fixation and probed with anti-clathrin HC mAb X22 (C), or serum starved for 1 h, given 25 µg/ml Tf568 continuously for 15 min at 37°C, and fixed (D). Arrowheads indicate accumulation of transferrin on the cell surface in contrast to the control cells. Bar, 10 µm.

View larger version (67K): [in this window] [in a new window]   Figure 7. Rescue of AP-2 knockdown with β2-YFP. (A) Lysates of HeLa SS6 cells untreated (lane a) or treated with either AP-2 subunit (lane b), both AP-1 β1 subunit and AP-2 β2 subunit siRNA (lane c) along with full-length β2-YFP (lane d), or β2-YFPTRNK (lane e) were resolved by SDS-PAGE and transferred to nitrocellulose. Sections of the blots were probed with the anti-clathrin HC mAb TD.1 and anti-β1/β2 subunit mAb 100/1, anti-GFP antibody, anti-AP-2 subunit mAb clone 8, anti-AP-2 µ2 subunit antiserum, or anti-AP-1 subunit antibody AE/1 and only the relevant portions show. (B–F) Mock-transfected (B and E) or β1 + β2 subunit siRNA-transfected (C, D, and F) HeLa SS6 cells were transfected with either full-length β2-YFP (B–D) or β2-YFPTRNK (E and F) (green in merged images), and either surface labeled with Tf568 (B, C, E, and F) (red in merged images) and fixed, or incubated with Tf568 continuously for 15 min at 37°C, fixed, and probed with anti-AP-2 subunit mAb AP.6 (D) (blue in merged image). Note that β2-YFP–expressing cells cluster transferrin at the surface (C) and do not have the typical circumferential band of transferrin at 15 min (D; arrowheads) and that the β2-YFPTRNK restores clustering of surface transferrin receptors (F) as well. Bar, 10 µm.

View larger version (49K): [in this window] [in a new window]   Figure 8. ARH requires the β2 appendage platform for plasma membrane localization. HeLa SS6 cells transfected with β1 + β2 subunit siRNAs and either full-length β2-YFP (A), β2-YFP trunk (B), or full-length β2-YFP bearing Y888V (C), or dual Y815A and LLNLD (D) mutations (left column) were incubated with 50 µg/ml Tf633 for 15 min at 37°C, permeabilized, fixed and stained with polyclonal anti-ARH antibodies (right column). (E) A comparison of the fluorescence intensity between β2-YFP–transfected cells and knockdown cells (as determined by lack of Tf633 internalization) shows the differences between β2-YFP fusions that can recruit ARH to the membrane and those that cannot. No rescue indicates the difference in ARH intensity between wild-type and β1 + β2 knocked down cells.

To attempt to distinguish between the two models, we used a mutant form of β-arrestin 1. Wild-type β-arrestins remain diffusely cytosolic in the absence of GPCR stimulation (Laporte et al., 2000; Santini et al., 2002; Scott et al., 2002) (Figure 9A) by maintaining a basal, inactive conformation. Several closely spaced residues within the C-terminal [DE]_nX_1-2FXX[FL]XXXR motif interact with the major folded N-terminal region of β-arrestin, rigidifying the protein and attenuating the CLASPs ability to engage the assembling clathrin machinery (Kim and Benovic, 2002; Gurevich and Gurevich, 2004; Edeling et al., 2006a; Burtey et al., 2007). In β-arrestin 1, immediately preceding the proximal Phe388 of the β2 platform binding motif are Ile386 and Val387. Double substitution of these residues to Ala (IVAA) results in constitutive association of β-arrestin 1 with clathrin-coated structures in the absence of any GPCR activation (Burtey et al., 2007). If β-arrestins only remain associated with surface coated structures by switching to clathrin when assembling clathrin binds the AP-2 β2 subunit appendage, then deletion or mutation of the β-arrestin 1 clathrin box sequence ³⁷⁶LIELD should prevent the IVAA mutant from colocalizing extensively with clathrin-coated structures at the plasma membrane.

View larger version (78K): [in this window] [in a new window]   Figure 9. Clathrin-binding deficient β-arrestin 1 associates with AP-2. HeLa SS6 cells stably expressing β2-YFP were transiently transfected with wild-type (WT) tdRFP-β-arrestin 1 (A), tdRFP-β-arrestin 1 with the IVAA activating mutation (B), or tdRFP-β-arrestin 1 (IVAA) + clathrin box mutation LIELAAEA (C) or + clathrin box deletion LIELD (D). Approximately 18 h after transfection, cells were imaged by TIR-FM to selectively observe the ventral surface. Representative images show tdRFP-β-arrestin 1 (left column), β2-YFP (middle column), and merged (right column) signals. Note that despite a considerable cytosolic pool, there is near complete colocalization of β2-YFP puncta with the tdRFP-β-arrestin 1 (IVAA) alone or with either clathrin box disruption. Bar, 10 µm.

There are several distinct classes of clathrin-coated structures on the ventral surface of HeLa SS6 cells (Keyel et al., 2004), and the IVAA β-arrestin 1 mutants localize to all of these. Analysis of the dynamics of de novo-forming puncta reveals that, like the tdRFP-β-arrestin 1 (IVAA) (Figure 10, A–C), the IVAA+LIELD mutant concentrates at, and then disappears with, β2-YFP–tagged AP-2 structures (Figure 10 D–F). We do not observe earlier loss of the IVAA+LIELD tdRFP-β-arrestin 1 mutant from these patches that would indicate failure to switch to a strictly clathrin-dependent mode of association. Very similar results are obtained using BS-C-1 cells stably expressing GFP-tagged clathrin light chain (data not shown), a cell line that exhibits de novo coat formation almost exclusively (Ehrlich et al., 2004).

View larger version (105K): [in this window] [in a new window]   Figure 10. Clathrin-binding deficient β-arrestin 1 dynamically associates with AP-2. HeLa SS6 cells stably expressing β2-YFP were transiently transfected with tdRFP-β-arrestin 1 (IVAA) (A–C) or tdRFP-β-arrestin 1 (IVAA+LIELD) (D–F). Approximately 18 h after transfection, cells were imaged by TIR-FM at one frame every 5 s. (A) Representative frames from the tdRFP-β-arrestin 1 (IVAA)–expressing cells. β-arrestin 1 (left frame) and β2-YFP (middle frame) show extensive colocalization (right frame). (B) A sequence of frames at 25-s intervals shows the simultaneous disappearance of tdRFP-β-arrestin 1 (IVAA) (middle row) and β2-YFP (bottom row) from the evanescent field. The spot is the same as that boxed in A. (C) A line drawn along the axis of the box in A was used to create a kymograph. tdRFP-β-arrestin 1 IVAA (left column) and β2-YFP (middle column) leave the evanescent field together (right column). (D) tdRFP-β-arrestin 1 (IVAA+LIELD)–expressing cells likewise show significant overlap with β2-YFP as in depicted in A. (E) The boxed spot in D containing tdRFP-β-arrestin 1 (IVAA+LIELD) (middle row) and β2-YFP (bottom row) disappears from the field (solid arrowhead) at 100 s as a second spot containing both proteins appears (open arrowhead). (F) A line drawn along the axis of the box in D was used to create a kymograph. tdRFP-β-arrestin 1 (IVAA+LIELD) (left column) and β2-YFP (middle column) disappear together, whereas the appearance of arrestin in the second spot is slightly preceded by β2-YFP. All horizontal bars, 10 µm (A and D); vertical time bars, 60 s (C and F).

View larger version (71K): [in this window] [in a new window]   Figure 11. Clathrin-binding deficient β-arrestin 1 associates with clathrin-coated structures in the absence of endogenous β-arrestins. Wild-type and β-arrestin 1/2 null mouse embryonic fibroblasts were lysed and resolved by SDS-PAGE (A; left) and transferred to nitrocellulose (A; right). Portions of the blots were probed with an anti-β-arrestin polyclonal antibody, anti-clathrin HC mAb TD.1, and anti-β1/β2 subunit mAb 100/1, or with anti-tubulin mAb E7. The position of the molecular mass standards (in kilodaltons) is noted on the left. Alternatively, β-arrestin 1/2 null mouse embryonic fibroblasts were transiently transfected with tdRFP-β-arrestin 1 (red) wild type (B), the tdRFP-β-arrestin 1 (IVAA)-activating mutation (C), IVAA + clathrin box mutation LIELAAEA (D), or IVAA + clathrin box deletion LIELD (E). At 18 h after transfection, cells were incubated with 25 µg/ml Tf488 (green) on 4°C on ice for 1 h to label transferrin receptor in clathrin-coated structures, and then they were rapidly imaged at 17°C by TIR-FM. Under these conditions, transferrin is found both at clathrin coated structures on the cell surface and already in peripheral endosomes. Magnified insets are denoted by white boxes; the IVAA and IVAA + clathrin box disruption β-arrestin mutants (middle inset) both colocalize with Tf488 (top inset), as denoted by arrowheads. Bar, 10 µm.

View larger version (69K): [in this window] [in a new window]   Figure 12. Down-regulation of the type 1 angiotensin II receptor by both tdRFP-β-arrestin 1 (IVAA) and β-arrestin (IVAA+LIELD). HEK293 cells stably expressing FLAG-tagged type I angiotensin II receptor were transiently transfected with tdRFP-β-arrestin 1 (IVAA) (A), or tdRFP-β-arrestin 1 (IVAA+LIELD) (B). Cells were starved for 1 h in starvation medium and then stimulated with 100 nM angiotensin II conjugated to Alexa488 (AngII; green) for 0, 5, or 20 min. Cells were washed, fixed, and examined by confocal microscopy. Representative images of medial focal planes are shown. Before stimulation, β-arrestin is largely diffuse in the cytosol but also present at the plasma membrane (arrows) or at a juxtanuclear location (asterisks). After 5 min of stimulation, β-arrestin clusters with angiotensin II at the plasma membrane (closed arrowheads), and on endosomes (open arrowheads). At 20 min after stimulation, nearly all β-arrestin and angiotensin II colocalize on larger endosomes. Bar. 10 µm.

	DISCUSSION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Because of the high degree of sequence identity between the adaptor β1 and β2 subunits, gene silencing or targeted gene disruption of the β2 subunit results in only a moderate endocytic phenotype. β2 is probably the only subunit of AP-2 that can be replaced by an AP-1 counterpart, because the 1 subunit does not interact directly with the subunit (Page and Robinson, 1995), and µ2 subunit RNAi phenocopies the subunit RNAi (Motley et al., 2003; Huang et al., 2004). We suspect that the opposite is also true, because it is known that β2 subunits can incorporate into AP-1 in vivo (Page and Robinson, 1995; Sorkin et al., 1995; Traub et al., 1996). Also, at moderately high levels, ectopically expressed β2-YFP can incorporate into AP-1 (Huang et al., 2003; Keyel et al., 2004), and the C-terminal region of ARH interacts similarly with AP-1 and AP-2 but not with AP-3 (He et al., 2002; Mishra et al., 2002b). All of the key specificity-determining residues at the platform and sandwich subdomain interaction interfaces are conserved between the β1 and β2 polypeptides. This must account for the functional activity of a hybrid AP-2 incorporating a β1 chain. The apparent interchangeability of the β1 and β2 subunits, the localization of some eps15 at a juxtanuclear, TGN-like location (Tebar et al., 1996; Kent et al., 2002), and our detection of the β-arrestin 1 (IVAA) mutant at the juxtanuclear/TGN region (Figure 12) raises the question of whether known AP-2 β2 binding partners also function normally together with AP-1. A very recent study in fact mapped an apparent AP-1–specific binding site on eps15 to the sequence ⁷²⁰ESFDGDFADFSTLS (Chi et al., 2008). Remarkably, this region is identical to a peptide segment of eps15 cocrystallized at the sandwich site of the AP-2 β2 appendage (Schmid et al., 2006). The reason why deletion of this amino acid tract from eps15 perturbs only AP-1 binding (Chi et al., 2008) is because the proximal tract of >10 DPF triplets facilitates AP-2 engagement through interaction with the platform subdomain of the subunit appendage (Owen et al., 1999; Brett et al., 2002); the appendage of the analogous subunit in AP-1, the subunit, lacks a platform subdomain, and binds eps15 only very weakly (Kent et al., 2002; Nogi et al., 2002). The fact that overexpression of an eps15 mutant lacking the above-mentioned 14-amino acid β-binding tract sharply slows exit of the MPR from the TGN (Chi et al., 2008) argues that the β1 and β2 subunits do perform some similar functions at the TGN/endosome and plasma membrane, respectively.

Because eps15 contacts the β2 appendage through the sandwich subdomain, a mutation that disrupts this interaction surface interferes with eps15 binding (Edeling et al., 2006a; Schmid et al., 2006). We find that this same mutation (Y815A) abolishes clathrin binding, indicating that eps15 and clathrin compete for a common site on the β2 appendage sandwich subdomain (Edeling et al., 2006a). Biochemical experiments show plainly that eps15 preloaded onto AP-2 is expelled upon clathrin assembly and eps15 fails to be incorporated along with AP-2 into assembled clathrin coats (Cupers et al., 1998). By contrast, ARH and the β-arrestins differ significantly from eps15 and several other CLASPs and accessory factors in that they both display only a single AP-2 binding determinant with an absolute selectivity for the platform subdomain of the β2 appendage (Laporte et al., 2000; He et al., 2002; Mishra et al., 2002b). Substantial data attest to the critical and selective importance of the β2 appendage in the initial recruitment of GPCR·β-arrestin complexes to pre-existing sites of clathrin assembly. The clathrin box is located within a flexible, unstructured C-terminal loop (Milano et al., 2002), even in the basal β-arrestin conformation. Yet β-arrestins are cytosolic in the absence of GPCR activation (Hamdan et al., 2007), so, although the clathrin box is potentially accessible to the clathrin terminal domain, if the distal [DE]_nX_1-2FXX[FL]XXXR sequence is conformationally restrained, β-arrestins fail to associate appreciably with clathrin-coated structures. Similarly, when fused to GFP, the C-terminal region of β-arrestin 2 populates AP-2–positive clathrin structures at the cell surface but this colocalization is completely lost if the [DE]_nX_1-2FXX[FL]XXXR sequence is disrupted, even with an intact adjacent clathrin box (Schmid et al., 2006). Also, the β-arrestin 1 IVFAAA triple mutant is not colocalized with AP-2 at steady state, despite the conformation relaxation affected by the IV to AA substitution (Burtey et al., 2007). Mutagenic inactivation of the AP-2 binding sequence in β-arrestin 2 still allows translocation of this CLASP to agonist-stimulated GPCRs on the cell surface, but clustering at AP-2–positive puncta is lost, again despite an intact clathrin box (Laporte et al., 2000). Indeed, bioluminescence resonance energy transfer studies show that β-arrestin binding to liganded GPCRs temporally precedes an AP-2 β2 appendage interaction (Hamdan et al., 2007) and that mutation of the interaction surface on the β2 platform subdomain prevents energy transfer to AP-2 (Hamdan et al., 2007). By contrast, even with an inactivating mutation or complete deletion of the clathrin box, β-arrestin 1 still targets to clathrin-coated structures (Figures 9–12). Altogether, this argues strongly that the [DE]_nX_1-2FXX[FL]XXXR sequence is the principal determinant governing initial linkage of GPCRs with the endocytic machinery (Laporte et al., 2000).

Our siRNA/reconstitution experiments reveal that ARH likewise uses the analogous interaction motif as the primary mode of clathrin-coat engagement. In fact, simultaneous gene silencing of AP-2 and Dab2 leads to stalling of the LDL receptor at the cell surface despite normal ARH levels and the clear presence of surface clathrin coats (Keyel et al., 2006; Maurer and Cooper, 2006). The binding affinity of ARH (and β-arrestin) for the β2 appendage is greater than its affinity for any other binding partner. ARH binds to the β2 appendage, with a K_D value of 1 µM (Mishra et al., 2005), compared with 22 µM for a type I clathrin box LLDLD binding to clathrin (Miele et al., 2004), 10–100 µM for the Shc PTB domain binding to PtdIns(4,5)P₂ (Zhou et al., 1995), and 2–5 µM for various PTB domains binding to FXNPXY peptides (Li et al., 1998; Howell et al., 1999; Stolt et al., 2003; Stolt et al., 2005). In a sequential hub model for clathrin-coated vesicle assembly, it is proposed that AP-2–dependent interactions are diminished as clathrin buds progress toward late-stage events (Schmid et al., 2006; Schmid and McMahon, 2007). In fact, it is conjectured that ARH and β-arrestins only remain associated with deeply invaginated buds by interacting directly with clathrin heavy chains (Schmid et al., 2006). Given the 10-fold difference in binding affinity for the β2 appendage and the clathrin terminal domain, which is also subject to direct competition by numerous other CLASPs and accessory proteins that have tandemly repeated clathrin boxes and are massed at the bud site (Robinson, 2004; Sorkin, 2004; Maldonado-Baez and Wendland, 2006), the biological advantage of moving to an apparently lower affinity association (at the clathrin hub) is not obvious.

The changing hub model was formulated, in part, to account for the inherent directionality of the clathrin-coat assembly process (Schmid et al., 2006; Schmid and McMahon, 2007). Although our view is that CLASPs like ARH and β-arrestin, which associate physically with AP-2 through the β2 appendage, do not necessarily switch to a clathrin-dependent interaction mode in a temporally-defined manner, our observations certainly do not generally invalidate the model, which invokes changing degrees of freedom as a function of ongoing lattice assembly events. Nor do our findings indicate that the clathrin box in either ARH or β-arrestin is functionally insignificant (Krupnick et al., 1997; Laporte et al., 2000; Kim and Benovic, 2002; Santini et al., 2002; Garuti et al., 2005). Rather, our data agree with several independent investigations showing the β-arrestin·AP-2 interaction typically initiates clustering of GPCRs into clathrin-coated structures and simply preclude ARH and β-arrestins from the set of potential endocytic factors subject to displacement by assembling clathrin triskelia. Intriguingly, because of the clear functional redundancy between the adaptor β1 and β2 subunits, and because only a single pool of cytosolic clathrin is used to construct all clathrin-coats within the cell, use of neither the [DE]_nX_1-2FXX[FL]XXXR motif nor the clathrin box will ensure translocation of β-arrestin or ARH to only those AP-2 and clathrin-containing structures positioned at the cell surface. However, both the β-arrestins (Gaidarov et al., 1999; Milano et al., 2002) and ARH (Mishra et al., 2002b) bind to PtdIns(4,5)P₂, a lipid concentrated in the inner leaflet of the plasma membrane. The phenomenon of coincidence detection, involving simultaneous contacts with transmembrane cargo receptors, lipids, AP-2, and then clathrin, likely provides the necessary selectivity. The striking translocation of the cytosolic pool of β-arrestin 1 upon angiotensin II application (Figure 12) is a graphic demonstration of this avidity-based phenomenon. Overall then, the β2 appendage of AP-2 represents one hub within an intricate web of protein–protein interactions that promotes selective cargo endocytosis by facilitating initial CLASP recruitment.

	ACKNOWLEDGMENTS

 
We thank Sasha Sorkin for generously sharing the β2-YFP plasmid, Robert Lefkowitz for providing the arrestin-null mouse fibroblasts, Stéphane Laporte for the angiotensin II receptor-expressing HEK cells, and members of the Traub laboratory for critical reading of the manuscript. This work was funded by National Institutes of Health grants R01 DK53249 (to L.M.T.) and DE015180 (to E.T.E.), American Heart Association (AHA) Established Investigator Award 0540007N (to L.M.T.), and AHA predoctoral fellowship 0415428U (to P.A.K.).

	Footnotes

 
This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E08-07-0712) on October 8, 2008.

These authors contributed equally to this work.

Present address: Department of Medicine and Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110.

Address correspondence to: Linton M. Traub (traub{at}pitt.edu)

Abbreviations used: ARH, autosomal recessive hypercholesterolemia protein; CLASP, clathrin-associated sorting protein; Dab2, disabled-2; EGFP, enhanced green fluorescent protein; GPCR, G protein-coupled receptor; HC, heavy chain; LDL, low-density lipoprotein; mAb, monoclonal antibody; MPR, cation-independent mannose 6-phosphate receptor; PtdIns(4,5)P₂, phosphatidylinositol 4,5-bisphosphate; PTB, phosphotyrosine binding; tdRFP, tandem dimer tomato; Tf488, transferrin conjugated to Alexa Fluor 488; Tf568, transferrin conjugated to Alexa Fluor 568; Tf633, transferrin conjugated to Alexa Fluor 633; YFP, yellow fluorescent protein.

	REFERENCES

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Aguilar, R. C., Ohno, H., Roche, K. W., and Bonifacino, J. S. (1997). Functional domain mapping of the clathrin-associated adaptor medium chains µ1 and µ2. J. Biol. Chem 272, 27160–27166.[Abstract/Free Full Text]

Ahle, S., Mann, A., Eichelsbacher, U., and Ungewickell, U. (1988). Structural relationships between clathrin assembly proteins from the Golgi and the plasma membrane. EMBO J 7, 919–929.[Medline]

Bairstow, S. F., Ling, K., Su, X., Firestone, A. J., Carbonara, C., and Anderson, R. A. (2006). Type I 661 phosphatidylinositol phosphate kinase directly interacts with AP2 and regulates endocytosis. J. Biol. Chem 281, 20632–20642.[Abstract/Free Full Text]

Barriere, H., Nemes, C., Lechardeur, D., Khan-Mohammad, M., Fruh, K., and Lukacs, G. L. (2006). Molecular basis of Ub-dependent internalization of membrane proteins in mammalian cells. Traffic 7, 282–297.[CrossRef][Medline]

Blondeau, F. et al. (2004). Tandem MS analysis of brain clathrin-coated vesicles reveals their critical involvement in synaptic vesicle recycling. Proc. Natl. Acad. Sci. USA 101, 3833–3838.[Abstract/Free Full Text]

Brett, T. J., and Traub, L. M. (2006). Molecular structures of coat and coat-associated proteins: function follows form. Curr. Opin. Cell Biol 18, 395–406.[CrossRef][Medline]

Brett, T. J., Traub, L. M., and Fremont, D. H. (2002). Accessory protein recruitment motifs in clathrin-mediated endocytosis. Structure 10, 797–809.[Medline]

Brodsky, F. M. (1985). Clathrin structure characterized with monoclonal antibodies. II. Identification of in vivo forms of clathrin. J. Cell Biol 101, 2055–2062.[Abstract/Free Full Text]

Burtey, A., Schmid, E. M., Ford, M. G., Rappoport, J. Z., Scott, M. G., Marullo, S., Simon, S. M., McMahon, H. T., and Benmerah, A. (2007). The conserved isoleucine-valine-phenylalanine motif couples activation state and endocytic functions of β-arrestins. Traffic 8, 914–931.[CrossRef][Medline]

Camidge, D. R., and Pearse, B.M.F. (1994). Cloning of the Drosophila β-adaptin and its localization on expression in mammalian cells. J. Cell Sci 107, 709–718.[Abstract]

Chaudhuri, R., Lindwasser, O. W., Smith, W. J., Hurley, J. H., and Bonifacino, J. S. (2007). CD4 downregulation by HIV-1 Nef is dependent on clathrin and involves a direct interaction of Nef with the AP2 clathrin adaptor. J. Virol 81, 3877–3890.[Abstract/Free Full Text]

Chi, S., Cao, H., Chen, J., and McNiven, M. (2008). Eps15 mediates vesicle trafficking from the trans-Golgi network via an interaction with clathrin adaptor AP-1. Mol. Biol. Cell 19, 3564–3575.[Abstract/Free Full Text]

Chin, D. J., Straubinger, R. M., Acton, S., Nathke, I., and Brodsky, F. M. (1989). 100-kDa polypeptides in peripheral clathrin-coated vesicles are required for receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA 86, 9289–9293.[Abstract/Free Full Text]

Coleman, S. H., Van Damme, N., Day, J. R., Noviello, C. M., Hitchin, D., Madrid, R., Benichou, S., and Guatelli, J. C. (2005). Leucine-specific, functional interactions between human immunodeficiency virus type 1 Nef and adaptor protein complexes. J. Virol 79, 2066–2078.[Abstract/Free Full Text]

Collins, B. M., McCoy, A. J., Kent, H. M., Evans, P. R., and Owen, D. J. (2002). Molecular architecture and functional model of the endocytic AP2 complex. Cell 109, 523–535.[CrossRef][Medline]

Conner, S. D., and Schmid, S. L. (2003). Regulated portals of entry into the cell. Nature 422, 37–44.[CrossRef][Medline]

Cupers, P., Jadhav, A. P., and Kirchhausen, T. (1998). Assembly of clathrin coats disrupts the association between Eps15 and AP-2 adaptors. J. Biol. Chem 273, 1847–1850.[Abstract/Free Full Text]

Dalal, S., Rosser, M. F., Cyr, D. M., and Hanson, P. I. (2004). Distinct roles for the AAA ATPases NSF and p97 in the secretory pathway. Mol. Biol. Cell 15, 637–648.[Abstract/Free Full Text]

Drake, M. T., Downs, M. A., and Traub, L. M. (2000). Epsin binds to clathrin by associating directly with the clathrin-terminal domain: evidence for cooperative binding through two discrete sites. J. Biol. Chem 275, 6479–6489.[Abstract/Free Full Text]

Edeling, M. A., Mishra, S. K., Keyel, P. A., Steinhauser, A. L., Collins, B. M., Roth, R., Heuser, J. E., Owen, D. J., and Traub, L. M. (2006a). Molecular switches involving the AP-2 β2 appendage regulate endocytic cargo selection and clathrin coat assembly. Dev. Cell 10, 329–342.[CrossRef][Medline]

Edeling, M. A., Smith, C., and Owen, D. (2006b). Life of a clathrin coat: insights from clathrin and AP structures. Nat. Rev. Mol. Cell Biol 7, 32–44.[Medline]

Eden, E. R., Naoumova, R. P., Burden, J. J., McCarthy, M. I., and Soutar, A. K. (2001). Use of homozygosity mapping to identify a region on chromosome 1 bearing a defective gene that causes autosomal recessive homozygous hypercholesterolemia in two unrelated families. Am. J. Hum. Genet 68, 653–660.[CrossRef][Medline]

Eden, E. R., Patel, D. D., Sun, X., Burden, J. J., Themis, M., Edwards, M., Lee, P., Neuwirth, C., Naoumova, R. P., and Soutar, A. K. (2002). Restoration of LDL-receptor function in cells from patients with autosomal recessive hypercholesterolemia by retroviral expression of ARH1. J. Clin. Invest 110, 1695–1702.[CrossRef][Medline]

Eden, E. R., Sun, X. M., Patel, D. D., and Soutar, A. K. (2007). Adaptor protein Disabled-2 modulates low density lipoprotein (LDL) receptor synthesis in fibroblasts from patients with autosomal recessive hypercholesterolemia. Hum. Mol. Genet 16, 2751–2759.[Abstract/Free Full Text]

Ehrlich, M., Boll, W., Van Oijen, A., Hariharan, R., Chandran, K., Nibert, M. L., and Kirchhausen, T. (2004). Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell 118, 591–605.[CrossRef][Medline]

Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498.[CrossRef][Medline]

Gaidarov, I., and Keen, J. H. (1999). Phosphoinositide-AP-2 interactions required for targeting to plasma membrane clathrin-coated pits. J. Cell Biol 146, 755–764.[Abstract/Free Full Text]

Gaidarov, I., Krupnick, J. G., Falck, J. R., Benovic, J. L., and Keen, J. H. (1999). Arrestin function in G protein-coupled receptor endocytosis requires phosphoinositide binding. EMBO J 18, 871–881.[CrossRef][Medline]

Garcia, C. K. et al. (2001). Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 292, 1394–1398.[Abstract/Free Full Text]

Garuti, R., Jones, C., Li, W. P., Michaely, P., Herz, J., Gerard, R. D., Cohen, J. C., and Hobbs, H. H. (2005). The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pits. J. Biol. Chem 280, 40996–41004.[Abstract/Free Full Text]

Ghosh, P., Dahms, N. M., and Kornfeld, S. (2003). Mannose 6-phosphate receptors: new twists in the tale. Nat. Rev. Mol. Cell Biol 4, 202–213.[CrossRef][Medline]

Girard, M., Allaire, P. D., McPherson, P. S., and Blondeau, F. (2005). Non-stoichiometric relationship between clathrin heavy and light chains revealed by quantitative comparative proteomics of clathrin-coated vesicles from brain and liver. Mol. Cell. Proteomics 4, 1145–1154.[Abstract/Free Full Text]

Gonzalez-Gaitan, M., and Jackle, H. (1997). Role of Drosophila -adaptin in presynaptic vesicle recycling. Cell 88, 767–776.[CrossRef][Medline]

Grant, B., and Hirsh, D. (1999). Receptor-mediated endocytosis in the Caenorhabditis elegans oocyte. Mol. Biol. Cell 10, 4311–4326.[Abstract/Free Full Text]

Gurevich, V. V., and Gurevich, E. V. (2004). The molecular acrobatics of arrestin activation. Trends Pharmacol. Sci 25, 105–111.[CrossRef][Medline]

Haffner, C., Paolo, G. D., Rosenthal, J. A., and de Camilli, P. (2000). Direct interaction of the 170 kDa isoform of synaptojanin 1 with clathrin and with the clathrin adaptor AP-2. Curr. Biol 10, 471–474.[CrossRef][Medline]

Hamdan, F. F., Rochdi, M. D., Breton, B., Fessart, D., Michaud, D. E., Charest, P. G., Laporte, S. A., and Bouvier, M. (2007). Unraveling G protein-coupled receptor endocytosis pathways using real-time monitoring of agonist-promoted interaction between β-arrestins and AP-2. J. Biol. Chem 282, 29089–29100.[Abstract/Free Full Text]

Hanson, S. M., Dawson, E. S., Francis, D. J., Van Eps, N., Klug, C. S., Hubbell, W. L., Meiler, J., and Gurevich, V. V. (2008a). A model for the solution structure of the rod arrestin tetramer. Structure 16, 924–934.

Hanson, S. M., Vishnivetskiy, S. A., Hubbell, W. L., and Gurevich, V. V. (2008b). Opposing effects of inositol hexakisphosphate on rod arrestin and arrestin2 self-association. Biochemistry 47, 1070–1075.[CrossRef][Medline]

Harasaki, K., Lubben, N. B., Harbour, M., Taylor, M. J., and Robinson, M. S. (2005). Sorting of major cargo glycoproteins into clathrin-coated vesicles. Traffic 6, 1014–1026.[CrossRef][Medline]

Hawryluk, M. J., Keyel, P. A., Mishra, S. K., Watkins, S. C., Heuser, J. E., and Traub, L. M. (2006). Epsin 1 is a polyubiquitin-selective clathrin-associated sorting protein. Traffic 7, 262–281.[CrossRef][Medline]

He, G., Gupta, S., Yi, M., Michaely, P., Hobbs, H. H., and Cohen, J. C. (2002). ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin and AP-2. J. Biol. Chem 277, 44044–44049.[Abstract/Free Full Text]

Heuser, J. (2000). The production of ‘cell cortices’ for light and electron microscopy. Traffic 1, 545–552.[CrossRef][Medline]

Hinrichsen, L., Harborth, J., Andrees, L., Weber, K., and Ungewickell, E. J. (2003). Effect of clathrin heavy chain- and -adaptin specific small interfering RNAs on endocytic accessory proteins and receptor trafficking in HeLa cells. J. Biol. Chem 278, 45160–45170.[Abstract/Free Full Text]

Höning, S., Ricotta, D., Krauss, M., Spate, K., Spolaore, B., Motley, A., Robinson, M., Robinson, C., Haucke, V., and Owen, D. J. (2005). Phosphatidylinositol-(4,5)-bisphosphate regulates sorting signal recognition by the clathrin-associated adaptor complex AP2. Mol. Cell 18, 519–531.[CrossRef][Medline]

Howell, B. W., Lanier, L. M., Frank, R., Gertler, F. B., and Cooper, J. A. (1999). The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids. Mol. Cell. Biol 19, 5179–5188.[Abstract/Free Full Text]

Huang, F., Jiang, X., and Sorkin, A. (2003). Tyrosine phosphorylation of the β2 subunit of clathrin adaptor complex AP-2 reveals the role of a di-leucine motif in the epidermal growth factor receptor trafficking. J. Biol. Chem 278, 43411–43417.[Abstract/Free Full Text]

Huang, F., Khvorova, A., Marshall, W., and Sorkin, A. (2004). Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference. J. Biol. Chem 279, 16657–16661.[Abstract/Free Full Text]

Janvier, K., and Bonifacino, J. S. (2005). Role of the endocytic machinery in the sorting of lysosome-associated membrane proteins. Mol. Biol. Cell 16, 4231–4242.[Abstract/Free Full Text]

Janvier, K., Kato, Y., Boehm, M., Rose, J. R., Martina, J. A., Kim, B. Y., Venkatesan, S., and Bonifacino, J. S. (2003). Recognition of dileucine-based sorting signals from HIV-1 Nef and LIMP-II by the AP-1 -1 and AP-3 -3 hemicomplexes. J. Cell Biol 163, 1281–1290.[Abstract/Free Full Text]

Jha, A., Agostinelli, N. R., Mishra, S. K., Keyel, P. A., Hawryluk, M. J., and Traub, L. M. (2004). A novel AP-2 adaptor interaction motif initially identified in the long-splice isoform of synaptojanin 1, SJ170. J. Biol. Chem 279, 2281–2290.[Abstract/Free Full Text]

Kaksonen, M., Toret, C. P., and Drubin, D. G. (2006). Harnessing actin dynamics for clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol 7, 404–414.[CrossRef][Medline]

Kalthoff, C., Alves, J., Urbanke, C., Knorr, R., and Ungewickell, E. J. (2002). Unusual structural organization of the endocytic proteins AP180 and epsin 1. J. Biol. Chem 277, 8209–8216.[Abstract/Free Full Text]

Kamikura, D. M., and Cooper, J. A. (2003). Lipoprotein receptors and a disabled family cytoplasmic adaptor protein regulate EGL-17/FGF export in. C. elegans. Genes Dev 17, 2798–2811.[Abstract/Free Full Text]

Kent, H., McMahon, H., Evans, P., Benmerah, A., and Owen, D. (2002). -adaptin appendage domain. Structure and binding site for Eps15 and -synergin. Structure 10, 1139–1148.[Medline]

Keyel, P. A., Mishra, S. K., Roth, R., Heuser, J. E., Watkins, S. C., and Traub, L. M. (2006). A single common portal for clathrin-mediated endocytosis of distinct cargo governed by cargo-selective adaptors. Mol. Biol. Cell 17, 4300–4317.[Abstract/Free Full Text]

Keyel, P. A., Watkins, S. C., and Traub, L. M. (2004). Endocytic adaptor molecules reveal an endosomal population of clathrin by total internal reflection fluorescence microscopy. J. Biol. Chem 279, 13190–13204.[Abstract/Free Full Text]

Kim, Y. M., and Benovic, J. L. (2002). Differential roles of arrestin-2 interaction with clathrin and adaptor protein 2 in G protein-coupled receptor trafficking. J. Biol. Chem 277, 30760–30768.[Abstract/Free Full Text]

Knuehl, C., Chen, C. Y., Manalo, V., Hwang, P. K., Ota, N., and Brodsky, F. M. (2006). Novel binding sites on clathrin and adaptors regulate distinct aspects of coat assembly. Traffic 7, 1688–1700.[CrossRef][Medline]

Kohout, T. A., Lin, F. S., Perry, S. J., Conner, D. A., and Lefkowitz, R. J. (2001). β-arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc. Natl. Acad. Sci. USA 98, 1601–1606.[Abstract/Free Full Text]

Krauss, M., Kukhtina, V., Pechstein, A., and Haucke, V. (2006). Stimulation of phosphatidylinositol kinase type I-mediated phosphatidylinositol (4,5)-bisphosphate synthesis by AP-2µ-cargo complexes. Proc. Natl. Acad. Sci. USA 103, 11934–11939.[Abstract/Free Full Text]

Krupnick, J. G., Santini, F., Gagnon, A. W., Keen, J. H., and Benovic, J. L. (1997). Modulation of the arrestin-clathrin interaction in cells. Characterization of beta-arrestin dominant-negative mutants. J. Biol. Chem 272, 32507–32512.[Abstract/Free Full Text]

Laporte, S. A., Miller, W. E., Kim, K. M., and Caron, M. G. (2002). β-arrestin/AP-2 interaction in G protein-coupled receptor internalization. Identification of a β-arrestin binding site in β2-adaptin. J. Biol. Chem 277, 9247–9254.[Abstract/Free Full Text]

Laporte, S. A., Oakley, R. H., Holt, J. A., Barak, L. S., and Caron, M. G. (2000). The interaction of β-arrestin with the AP-2 adaptor is required for the clustering of β₂-adrenergic receptor into clathrin-coated pits. J. Biol. Chem 275, 23120–23126.[Abstract/Free Full Text]

Li, S. C., Zwahlen, C., Vincent, S. J., McGlade, C. J., Kay, L. E., Pawson, T., and Forman-Kay, J. D. (1998). Structure of a Numb PTB domain-peptide complex suggests a basis for diverse binding specificity. Nat. Struct. Biol 5, 1075–1083.[CrossRef][Medline]

Lundmark, R., and Carlsson, S. R. (2002). The β-appendages of the four adaptor-protein (AP) complexes: structure and binding properties, and identification of sorting nexin 9 as an accessory protein to AP-2. Biochem. J 362, 597–607.[CrossRef][Medline]

Maldonado-Baez, L., and Wendland, B. (2006). Endocytic adaptors: recruiters, coordinators and regulators. Trends Cell Biol 16, 505–513.[CrossRef][Medline]

Maurer, M. E., and Cooper, J. A. (2006). The adaptor protein Dab2 sorts LDL receptors into coated pits independently of AP-2 and ARH. J. Cell Sci 119, 4235–4246.[Abstract/Free Full Text]

McCormick, P. J., Martina, J. A., and Bonifacino, J. S. (2005). Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments. Proc. Natl. Acad. Sci. USA 102, 7910–7915.[Abstract/Free Full Text]

McPherson, P. S., and Ritter, B. (2005). Peptide motifs: building the clathrin machinery. Mol. Neurobiol 32, 73–87.[CrossRef][Medline]

Miele, A. E., Watson, P. J., Evans, P. R., Traub, L. M., and Owen, D. J. (2004). Two distinct interaction motifs in amphiphysin bind two independent sites on the clathrin terminal domain β-propeller. Nat. Struct. Mol. Biol 11, 242–248.[CrossRef][Medline]

Milano, S. K., Kim, Y. M., Stefano, F. P., Benovic, J. L., and Brenner, C. (2006). Nonvisual arrestin oligomerization and cellular localization are regulated by inositol hexakisphosphate binding. J. Biol. Chem 281, 9812–9823.[Abstract/Free Full Text]

Milano, S. K., Pace, H. C., Kim, Y. M., Brenner, C., and Benovic, J. L. (2002). Scaffolding functions of arrestin-2 revealed by crystal structure and mutagenesis. Biochemistry 41, 3321–3328.

Mishra, S. K., Hawryluk, M. J., Brett, T. J., Keyel, P. A., Dupin, A. L., Jha, A., Heuser, J. E., Fremont, D. H., and Traub, L. M. (2004). Dual-engagement regulation of protein interactions with the AP-2 adaptor appendage. J. Biol. Chem 279, 46191–46203.[Abstract/Free Full Text]

Mishra, S. K., Keyel, P. A., Edeling, M. A., Owen, D. J., and Traub, L. M. (2005). Functional dissection of an AP-2 β2 appendage-binding sequence within the autosomal recessive hypercholesterolemia (ARH) protein. J. Biol. Chem 280, 19270–19280.[Abstract/Free Full Text]

Mishra, S. K., Keyel, P. A., Hawryluk, M. J., Agostinelli, N. R., Watkins, S. C., and Traub, L. M. (2002a). Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor. EMBO J 21, 4915–4926.[CrossRef][Medline]

Mishra, S. K., Watkins, S. C., and Traub, L. M. (2002b). The autosomal recessive hypercholesterolemia (ARH) protein interfaces directly with the clathrin-coat machinery. Proc. Natl. Acad. Sci. USA 99, 16099–16104.[Abstract/Free Full Text]

Mitsunari, T., Nakatsu, F., Shioda, N., Love, P. E., Grinberg, A., Bonifacino, J. S., and Ohno, H. (2005). Clathrin adaptor AP-2 is essential for early embryonal development. Mol. Cell. Biol 25, 9318–9323.[Abstract/Free Full Text]

Morris, S. M., and Cooper, J. A. (2001). Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2. Traffic 2, 111–123.[CrossRef][Medline]

Moskowitz, H. S., Yokoyama, C. T., and Ryan, T. A. (2005). Highly cooperative control of endocytosis by clathrin. Mol. Biol. Cell 16, 1769–1776.[Abstract/Free Full Text]

Motley, A., Bright, N. A., Seaman, M. N., and Robinson, M. S. (2003). Clathrin-mediated endocytosis in AP-2-depleted cells. J. Cell Biol 162, 909–918.[Abstract/Free Full Text]

Musacchio, A., Smith, C. J., Roseman, A. M., Harrison, S. C., Kirchhausen, T., and Pearse, B. M. (1999). Functional organization of clathrin in coats: combining electron cryomicroscopy and X-ray crystallography. Mol. Cell 3, 761–770.[CrossRef][Medline]

Nakano-Kobayashi, A., Yamazaki, M., Unoki, T., Hongu, T., Murata, C., Taguchi, R., Katada, T., Frohman, M. A., Yokozeki, T., and Kanaho, Y. (2007). Role of activation of PIP5K661 by AP-2 complex in synaptic vesicle endocytosis. EMBO J 26, 1105–1116.[CrossRef][Medline]

Nathke, I. S., Heuser, J., Lupas, A., Stock, J., Turck, C. W., and Brodsky, F. M. (1992). Folding and trimerization of clathrin subunits at the triskelion hub. Cell 68, 899–910.[CrossRef][Medline]

Nogi, T. et al. (2002). Structural basis for the accessory protein recruitment by the -adaptin ear domain. Nat. Struct. Biol 9, 527–531.[Medline]

Ohno, H., Stewart, J., Fournier, M.-C., Bosshart, H., Rhee, I., Miyatake, S., Saito, T., Galluser, A., Kirchhausen, T., and Bonifacino, J. S. (1995). Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science 269, 1872–1875.[Abstract/Free Full Text]

Owen, D. J., Vallis, Y., Noble, M. E., Hunter, J. B., Dafforn, T. R., Evans, P. R., and McMahon, H. T. (1999). A structural explanation for the binding of multiple ligands by the -adaptin appendage domain. Cell 97, 805–815.[CrossRef][Medline]

Owen, D. J., Vallis, Y., Pearse, B. M., McMahon, H. T., and Evans, P. R. (2000). The structure and function of the β2-adaptin appendage domain. EMBO J 19, 4216–4227.[CrossRef][Medline]

Page, L., and Robinson, M. (1995). Targeting signals and subunit interactions in coated vesicle adaptor complexes. J. Cell Biol 131, 619–630.[Abstract/Free Full Text]

Praefcke, G. J., Ford, M. G., Schmid, E. M., Olesen, L. E., Gallop, J. L., Peak-Chew, S. Y., Vallis, Y., Babu, M. M., Mills, I. G., and McMahon, H. T. (2004). Evolving nature of the AP2 -appendage hub during clathrin-coated vesicle endocytosis. EMBO J 23, 4371–4383.[CrossRef][Medline]

Rappoport, J. Z., and Simon, S. M. (2008). A functional GFP-fusion for imaging clathrin-mediated endocytosis. Traffic (in press).

Ritter, B., Denisov, A. Y., Philie, J., Deprez, C., Tung, E. C., Gehring, K., and McPherson, P. S. (2004). Two WXXF-based motifs in NECAPs define the specificity of accessory protein binding to AP-1 and AP-2. EMBO J 23, 3701–3710.[CrossRef][Medline]

Robinson, M. S. (2004). Adaptable adaptors for coated vesicles. Trends Cell Biol 14, 167–174.[CrossRef][Medline]

Rohrer, J., Schweizer, A., Russell, D., and Kornfeld, S. (1996). The targeting of lamp1 to lysosomes is dependent on the spacing of its cytoplasmic tail tyrosine sorting motif relative to the membrane. J. Cell Biol 132, 565–576.[Abstract/Free Full Text]

Santini, F., Gaidarov, I., and Keen, J. H. (2002). G protein-coupled receptor/arrestin3 modulation of the endocytic machinery. J. Cell Biol 156, 665–676.[Abstract/Free Full Text]

Schmid, E. M., Ford, M. G., Burtey, A., Praefcke, G. J., Peak Chew, S. Y., Mills, I. G., Benmerah, A., and McMahon, H. T. (2006). Role of the AP2 β-appendage hub in recruiting partners for clathrin coated vesicle assembly. PLoS Biol 4, e262.[CrossRef][Medline]

Schmid, E. M., and McMahon, H. T. (2007). Integrating molecular and network biology to decode endocytosis. Nature 448, 883–888.[CrossRef][Medline]

Scott, M. G., Benmerah, A., Muntaner, O., and Marullo, S. (2002). Recruitment of activated G protein-coupled receptors to pre-existing clathrin-coated pits in living cells. J. Biol. Chem 277, 3552–3559.[Abstract/Free Full Text]

Shaner, N. C., Campbell, R. E., Steinbach, P. A., Giepmans, B. N., Palmer, A. E., and Tsien, R. Y. (2004). Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol 22, 1567–1572.[CrossRef][Medline]

Shim, J., and Lee, J. (2000). Molecular genetic analysis of apm-2 and aps-2, genes encoding the medium and small chains of the AP-2 clathrin-associated protein complex in the nematode Caenorhabditis elegans. Mol. Cells 10, 309–316.[Medline]

Sorkin, A. (2004). Cargo recognition during clathrin-mediated endocytosis: a team effort. Curr. Opin. Cell Biol 16, 392–399.[CrossRef][Medline]

Sorkin, A., McKinsey, T., Shih, W., Kirchhausen, T., and Carpenter, G. (1995). Stoichiometric interaction of the epidermal growth factor receptor with the clathrin-associated protein complex AP-2. J. Biol. Chem 270, 619–625.[Abstract/Free Full Text]

Sorkina, T., Huang, F., Beguinot, L., and Sorkin, A. (2002). Effect of tyrosine kinase inhibitors on clathrin-coated pit recruitment and internalization of epidermal growth factor receptor. J. Biol. Chem 277, 27433–27441.[Abstract/Free Full Text]

Stolt, P. C., Chen, Y., Liu, P., Bock, H. H., Blacklow, S. C., and Herz, J. (2005). Phosphoinositide binding by the disabled-1 PTB domain is necessary for membrane localization and reelin signal transduction. J. Biol. Chem 280, 9671–9677.[Abstract/Free Full Text]

Stolt, P. C., Jeon, H., Song, H. K., Herz, J., Eck, M. J., and Blacklow, S. C. (2003). Origins of peptide selectivity and phosphoinositide binding revealed by structures of Disabled-1 PTB domain complexes. Structure 11, 569–579.[Medline]

Storez, H. et al. (2005). Homo- and hetero-oligomerization of β-arrestins in living cells. J. Biol. Chem 280, 40210–40215.[Abstract/Free Full Text]

Tebar, F., Sorkina, T., Sorkin, A., Ericsson, M., and Kirchhausen, T. (1996). eps15 is a component of clathrin-coated pits and vesicles and is located at the rim of clathrin-coated pits. J. Biol. Chem 271, 28727–28730.[Abstract/Free Full Text]

Traub, L. M. (2005). Common principles in clathrin-mediated sorting at the Golgi and the plasma membrane. Biochim. Biophys. Acta 1744, 415–437.[Medline]

Traub, L. M., Bannykh, S. I., Rodel, J. E., Aridor, M., Balch, W. E., and Kornfeld, S. (1996). AP-2–containing clathrin coats assemble on mature lysosomes. J. Cell Biol 135, 1801–1804.[Abstract/Free Full Text]

Traub, L. M., Downs, M. A., Westrich, J. L., and Fremont, D. H. (1999). Crystal structure of the appendage of AP-2 reveals a recruitment platform for clathrin-coat assembly. Proc. Natl. Acad. Sci. USA 96, 8907–8912.[Abstract/Free Full Text]

Traub, L. M., Kornfeld, S., and Ungewickell, E. (1995). Different domains of the AP-1 adaptor complex are required for Golgi membrane binding and clathrin recruitment. J. Biol. Chem 270, 4933–4942.[Abstract/Free Full Text]

Ungewickell, A., Ward, M. E., Ungewickell, E., and Majerus, P. W. (2004). The inositol polyphosphate 5-phosphatase Ocrl associates with endosomes that are partially coated with clathrin. Proc. Natl. Acad. Sci. USA 101, 13501–13506.[Abstract/Free Full Text]

Ungewickell, E. J., and Hinrichsen, L. (2007). Endocytosis: clathrin-mediated membrane budding. Curr. Opin. Cell Biol 19, 417–425.[CrossRef][Medline]

Walther, K., Diril, M. K., Jung, N., and Haucke, V. (2004). Functional dissection of the interactions of stonin 2 with the adaptor complex AP-2 and synaptotagmin. Proc. Natl. Acad. Sci. USA 101, 964–969.[Abstract/Free Full Text]

Wang, L. H., Sudhof, T. C., and Anderson, R. G. (1995). The appendage domain of -adaptin is a high affinity binding site for dynamin. J. Biol. Chem 270, 10079–10083.[Abstract/Free Full Text]

White, S., Miller, K., Hopkins, C., and Trowbridge, I. S. (1992). Monoclonal antibodies against defined epitopes of the human transferrin receptor cytoplasmic tail. Biochim. Biophys. Acta 1136, 28–34.[Medline]

Zhou, M. M., Ravichandran, K. S., Olejniczak, E. F., Petros, A. M., Meadows, R. P., Sattler, M., Harlan, J. E., Wade, W. S., Burakoff, S. J., and Fesik, S. W. (1995). Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature 378, 584–592.[CrossRef][Medline]

Zhu, Y., Traub, L. M., and Kornfeld, S. (1999). High-affinity binding of the AP-1 adaptor complex to trans-Golgi network membranes devoid of mannose 6-phosphate receptors. Mol. Biol. Cell 10, 537–549.[Abstract/Free Full Text]

This article has been cited by other articles:

				J. R. Thieman, S. K. Mishra, K. Ling, B. Doray, R. A. Anderson, and L. M. Traub Clathrin Regulates the Association of PIPKI{gamma}661 with the AP-2 Adaptor {beta}2 Appendage J. Biol. Chem., May 15, 2009; 284(20): 13924 - 13939. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Supplemental Materials All Versions of this Article: E08-07-0712v1 19/12/5309    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Keyel, P. A. Articles by Traub, L. M. Search for Related Content PubMed PubMed Citation Articles by Keyel, P. A. Articles by Traub, L. M.